Circulating tumor cells dynamics during chemotherapy predict survival and response in advanced non-small-cell lung cancer patients

BACKGROUND: Circulating tumor cells (CTCs) are prognostic biomarker in non-small-cell lung cancer (NSCLC). CTCs could also be used as predictor of efficacy of systemic treatments in advanced NSCLC. OBJECTIVES: We described the dynamic changes of CTCs during first-line platinum-based chemotherapy in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhen, Zhang, Xu-Chao, Feng, Wei-Neng, Zhang, Li, Liu, Xiao-Qing, Guo, Wei-Bang, Deng, Yan-Ming, Zou, Qing-Feng, Yang, Jin-Ji, Zhou, Qing, Wang, Bin-Chao, Chen, Hua-Jun, Tu, Hai-Yan, Yan, Hong-Hong, Wu, Yi-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126699/
https://www.ncbi.nlm.nih.gov/pubmed/37113733
http://dx.doi.org/10.1177/17588359231167818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126699/
https://www.ncbi.nlm.nih.gov/pubmed/37113733
http://dx.doi.org/10.1177/17588359231167818

Ejemplares similares